Information Presentation Formats

Meningioma Clinical Trial

Official title:

Information Presentation Formats and Pursuit of Diagnostic Information

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02267928
• Other study ID #: HS14-574
• Status: Completed
• Phase: N/A
• First received: October 14, 2014
• Last updated: August 1, 2016
• Start date: October 2014
• Est. completion date: May 2016

Study information

• Verified date: August 2016
• Source: Carnegie Mellon University
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Interventional

Clinical Trial Summary

Prevention and early detection of medical problems can greatly reduce health care costs, yet time and again, people avoid or ignore services that could help detect medical problems early enough to prevent or reduce the severity of potential problems. The investigators seek to understand whether the elicitation of symptom admission by patients can predict people's perceived risk of the medical condition and voluntary pursuit of medical information.

Description:

We will present individuals with medically accurate information about a medical condition and measure people's perceptions of their own likelihood to having that medical condition. This will include an opportunity for people to pursue more information by directing them to a website that features more information about the condition. The initial information provision will vary slightly in presentation (method of eliciting symptoms will vary), and the rate at which individuals visit the subsequent medical website to receive more information will be recorded as a measure of information seeking behavior. Rates will be compared across symptom elicitation conditions to determine which formats are most effective at encouraging information seeking about health issues. No personally identifying information will be collected, and all results will be reported in aggregate. Critically, no deception will be used: Participants will only be provided with information that is as accurate as possible (given existing knowledge in the health/medical fields).

Recruitment information / eligibility

• Status: Completed
• Enrollment: 305
• Est. completion date: May 2016
• Est. primary completion date: March 2016
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• 18 or older

• American

Exclusion Criteria:

• Mechanical Turk approval rate below 95%

Study Design

Allocation: Randomized, Intervention Model: Factorial Assignment, Masking: Single Blind (Subject), Primary Purpose: Screening

Related Conditions & MeSH terms

• Meningioma

Intervention

Other:
• Check Symptoms
Symptoms are "Checked"
• Uncheck Symptoms
Symptoms are "Un-checked"
• Experienced
Focus of instructions is on symptoms the participant has experienced
• Not Experienced
Focus of instructions is on symptoms the participant has NOT experienced

Locations

Country	Name	City	State
United States	Carnegie Mellon University	Pittsburgh	Pennsylvania

Sponsors (1)

Lead Sponsor	Collaborator
Carnegie Mellon University

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of symptoms	The number of symptoms checked off by participants	1 day	No
Primary	Risk of meningioma	Self-reported perceived risk of meningioma	1 day	No
Primary	Information pursuit	Binary measure of whether participants click to receive information about meningioma	1 day	No
Secondary	Funding allocation	Hypothetical federal funding allocation to meningioma	1 day	No
Secondary	Risk of serious disease	Perceived risk of having any serious disease	1 day	No